findmyKOL

Randolph Marshall, MD

Basic profile

Columbia University Irving Medical Center

ORCIDNPI
RegionNew York, NY · NortheastSpecialtyNeurologyFocusNeurology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPaymentsNone reportedNIH funding1995–2026Why? →

Randolph Marshall is a Neurology physician affiliated with Columbia University Irving Medical Center. OpenAlex indexes 327 publications with 10,954 citations (h-index 55); ClinicalTrials.gov lists 1 registered study matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
327publications

Distinct works indexed by OpenAlex, matched via ORCID.

10,954citations

Total citations across indexed works.

55h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials
10NIH grants · 1995–2026

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

710 W 168th St
New York, NY 100323726

Telephone

212-305-8389

Registry record last updated 16 Feb 2010.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    57.7%
    Statin36.5%
    Atorvastatin Calcium67%Rosuvastatin Calcium33%
    Part D<11 patients
    Cholesterol absorption inhibitor15.3%
    Ezetimibe100%
    Part D14 patients

    + 1 more class in this area

  • Nervous system

    29.6%
    Other antiepileptics16.4%
    Levetiracetam100%
    Part D<11 patients
    Anti-epileptic Agent6.9%
    Zonisamide100%
    Part D<11 patients

    + 1 more class in this area

  • Blood & clotting

    6.3%
    P2Y12 inhibitor6.3%
    Clopidogrel100%
    Part D<11 patients
Where care is delivered (Part B)13.1% facility · 86.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

10 NIH research awards on record, funded 19952026 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”